-
1
Study shows CXL is effective for keratoconus across ethnic groups.
-
2
570 eyes analyzed with follow-up of 3 years.
-
3
>80% of eyes stabilized/improved post-treatment.
-
4
Baseline disease severity is a key determinant of CXL effectiveness.
-
5
Ethnicity and age do not significantly affect treatment outcomes.
-
6
CXL should be offered broadly, not delayed due to demographics.
Original Source(s)
Related Content
AI Supports Glaucoma Surgical Planning
Predictive models identify high-risk patients and support earlier treatment decisions.
April 16, 2026
-
3 min
Radical Transparency: The Future of Ophthalmic Practice
As patient expectations and legal scrutiny rise, ophthalmology must strive to measure and document every step of care
by Mfazo Hove
April 16, 2026
-
6 min
Could Diet Help Prevent Myopia?
Dietary patterns linked to myopia risk in large study of Chinese schoolchildren
April 15, 2026
-
3 min
